Welcome to our dedicated page for Seacoast Bkg Fla SEC filings (Ticker: SBCF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Seacoast Banking Corporation of Florida filings document the regulatory record of a Florida bank holding company whose principal operating subsidiary is Seacoast National Bank. Its 8-K reports furnish quarterly and annual results, investor presentations, Regulation FD materials, securities-portfolio actions and other material events tied to bank earnings, deposits, net interest income, capital and liquidity.
Proxy and governance filings describe annual meeting matters, board composition, director elections, compensation and shareholder voting items. Transaction and capital-structure disclosures document completed bank acquisitions, amendments related to Series A Non-Voting Preferred Stock, rights of security holders and other matters affecting Seacoast's common and preferred equity.
Seacoast Banking Corporation of Florida executive vice president and chief risk officer Joseph M. Forlenza reported an equity award tied to prior performance. On February 10, 2026, he acquired 7,736 shares of common stock at $0 per share through performance-based restricted stock units granted on April 1, 2023, after the compensation committee certified results for the period ending December 31, 2025. These shares are scheduled to vest on December 31, 2026, if he remains in continuous service. He also reports direct ownership of multiple unvested time-based restricted stock awards and a stock option for 12,635 shares of common stock exercisable at $31.15 per share under the company’s Amended and Restated 2013 Incentive Plan.
Kleffel Juliette reported acquisition or exercise transactions in a Form 4 filing for SBCF. The filing lists transactions totaling 9,101 shares. Following the reported transactions, holdings were 70,638 shares.
Shaffer Charles M reported acquisition or exercise transactions in a Form 4 filing for SBCF. The filing lists transactions totaling 21,843 shares. Following the reported transactions, holdings were 167,884 shares.
Seacoast Banking Corp of Florida executive James C. Stallings III, EVP and Chief Credit Officer, reported an acquisition of 6,370 shares of common stock on February 10, 2026, at $0 per share as a grant or award.
The award relates to performance-based restricted stock units granted April 1, 2023, for which performance goals through December 31, 2025 were certified, and the shares are scheduled to vest on December 31, 2026, subject to continued service. The filing also lists separate unvested time-based restricted stock awards from 2023, 2024, and 2025 that vest in one-third increments over three years, contingent on continued employment.
State Street Corporation has filed a Schedule 13G reporting beneficial ownership of 4,610,754 shares of Seacoast Banking Corp of Florida common stock, representing 4.7% of the class as of the reported date. All voting and disposition authority is shared through affiliated investment adviser subsidiaries.
The filing states these shares were acquired and are held in the ordinary course of business, without any purpose or effect of changing or influencing control of Seacoast. State Street reports no sole voting or dispositive power, underscoring that authority rests collectively with its asset management entities.
Seacoast Banking Corporation of Florida director Jacqueline L. Bradley reported an option exercise and share sale. On 02/03/2026 she exercised 2,279 common stock rights at $14.39 per share and acquired the same number of common shares. She then sold 2,279 common shares at $33.54 per share, leaving 7,000 common shares held directly. She also beneficially owns 28,948 common shares held in Seacoast's Non-employee Directors Deferred Compensation Plan and continues to hold additional stock option grants under the company’s 2013 and 2021 incentive plans.
Seacoast Banking Corporation of Florida director Dennis J. Arczynski reported exercising and selling shares of the company’s common stock. On February 3, 2026, he exercised options for 3,419 shares of common stock at $14.39 per share and then sold 3,419 shares at $34.21 per share the same day.
After these transactions, he directly held 1,000 shares of common stock, with additional holdings reported in an LLC, a non‑employee directors deferred compensation plan, jointly with his spouse, and in a SEP plan. He also reported a remaining option position to buy 2,142 shares at an exercise price of $22.65 per share, expiring in 2027.
Seacoast Banking Corporation of Florida director Alvaro Monserrat reported exercising stock options into Seacoast common stock. On February 4, 2026, he exercised rights to buy 2,142, 1,431 and 970 shares at exercise prices of $22.65, $27.53 and $27.79 per share, respectively. These derivative positions were fully exercised, leaving no remaining options from those specific grants.
Following the transactions, Monserrat directly beneficially owned 23,778 shares of Seacoast common stock, including amounts held in Seacoast's Non-employee Directors Deferred Compensation Plan. The exercised options were originally granted under the company’s 2013 and 2021 incentive plans.
Seacoast Banking Corporation of Florida director Maryann Goebel reported an option exercise and share sale. On 02/03/2026, she exercised rights to buy 3,419 shares of common stock at $14.39 per share, then sold 3,419 shares at $34.23 per share.
After these transactions, she directly owns 6,000 shares of Seacoast common stock and holds a remaining 2,142-share stock right with an exercise price of $22.65 expiring on 02/06/2027. Some holdings are through a revocable trust and a non-employee directors deferred compensation plan.
A shareholder filed a Form 144 notice indicating an intent to sell 3,419 shares of common stock on the NASDAQ through Morgan Stanley Smith Barney LLC. The shares have an aggregate market value of 116,947.92 and are part of an issuer with 97,828,149 shares outstanding.
The filing shows the shares were acquired on 02/03/2026 via a stock option exercise paid in cash, with the approximate sale date also listed as 02/03/2026. Form 144 is a notice of a proposed sale by an affiliate or holder of restricted securities, rather than a confirmation that the sale has already occurred.